The Greater Intermountain Node
The Greater Intermountain Node (GIN) was founded in 2019 to expand the existing National Institute of Drug Abuse Clinical Trial Network (CTN) infrastructure by developing and testing innovative interventions for opioid use disorder, preventing overdose, expanding the settings for Network research, and bringing new research expertise of opioid addiction research to the Utah, regional, and national communities.
ABOUT THE GREATER INTERMOUNTAIN NODE
The Greater Intermountain Node (GIN) is housed within the Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA) at the University of Utah. The GIN brings particular expertise in three areas of opioid addiction research to the Utah, regional, and national communities:
- Research within non-addiction specialty health care settings.
- Addiction and opioid research within large health systems of care.
- Implementation science and approaches to bring addiction evidence based research to practice.
The GIN leverages robust institutional commitment and infrastructure, institutional centers focused on addiction-related research, and training programs with strong regional and national connections to clinicians, educators, other institutions and organizations, and community stakeholders.
Adam Gordon, MD, MPH
Dr. Adam Gordon is the Elbert F. and Marie Christensen Endowed Research Professor, tenured Professor of Medicine and Psychiatry, at the University of Utah School of Medicine and the Section Chief of Addiction Medicine at the VA Salt Lake City Health Care System. Dr. Gordon has a 20+ year track record of conducting research on the quality, equity, and efficiency of health care for vulnerable populations, including those who are homeless or who have addiction.
Gerald Cochran, PhD, MSW
Dr. Gerald Cochran is an Associate Professor in the Department of Internal Medicine, Division of Epidemiology at the University of Utah and also has an adjunct Associate Professor appointment with the University of Utah Department of Psychiatry and is core faculty with the Informatics, Decision-Enhancement, and Analytic Sciences (IDEAS) Center of Innovation within the VA Salt Lake City Health Care System.
YEAR I: 2019-2020
YEAR II: 2020-2021
Affiliate Faculty
A. Taylor Kelley, MD, MPH, MS
Ami Stuart, PhD, MA, MS
Ana Holtey, DO
Audrey Jones, PhD
Billi Tsuya, PA-C
Brian C. Sauer, PhD, MS
Christina L. Gallop, MD
Daniel W. Odell, MD
Eric L. Garland, PhD, LCSW
Jake S. Magel, PhD, DSc, MSPT
Jasmin E. Charles, PA-C, MPAS
Jeremy E. Thueson, MD
John W. Gardner, PharmD
Julie Day, MD
Julie M. Fritz, PhD, PT, ATC
Ken B. Johnson, MD, MS
Kristina Lisa Allen-Brady, PhD, MSPH, BA, MPT
Kristine A. Campbell, MD, MSc
Marcela C. Smid, MD, MA, MS
Mary Jo Pugh, PhD, RN
Matthew H. Samore, MD
Megan E. Vanneman, PhD, MPH
Michael A. Incze, MD, MSEd
Michelle Debbink, MD, PhD
Molly B. Conroy, MD, MPH, FACSM, FAHA
Nasser Sharareh, PhD
Nicholas Cox, PharmD, BCACP
Peter P. Taillac, MD
Russel J. Ragsdale
Scott R. Junkins, MD
Troy E. Madsen, MD, FACEP
OTHER NODES
CONTACT US:
Mailing Address:
383 Colorow Drive, Mailbox 16
Salt Lake City, Utah 84108
Email:
Phone:
(801) 213-0806
PARCKA
The Program for Addiction Research, Clinical Care, Knowledge, and Advocacy (PARCKA) promotes and provides addiction related research, clinical care, knowledge and advocacy across the University of Utah, the local community, the state, and the nation.
NIDA Clinical Trials Network
The National Institute of Drug Abuse (NIDA) Clinical Trial Network (CTN) provides an enterprise in which NIDA, treatment researchers, and community-based service providers work toward new treatment options in community-level clinical practice.
